rxfast.net Quick Pharmacy Navigator

Tag: Paragraph IV certification

Why the First Generic Drug Filer Gets 180 Days of Market Exclusivity
Pharmacy

Why the First Generic Drug Filer Gets 180 Days of Market Exclusivity

  • Gareth Wycliffe
  • Dec 10, 2025

The first generic drug filer gets 180 days of exclusive market rights under the Hatch-Waxman Act. This rule was meant to lower drug prices-but loopholes let companies delay competition. Here’s how it works, who benefits, and why reform is overdue.

Recent Posts
  • Understanding Penile Surgery for Phimosis Treatment: Risks and Benefits Dec 27, 2023
  • How to Appeal Insurance Denials for Generic Medications: A Step-by-Step Guide Jan 24, 2026
  • Managing Rosuvastatin Side Effects Naturally: Tips & Remedies Oct 26, 2025
  • Rheumatoid Arthritis: How Biologic DMARDs Can Lead to Disease Remission Dec 15, 2025
  • Pim-800 (Paracetamol) vs Common Pain Relievers: Detailed Comparison Oct 8, 2025
Categories
  • Health (85)
  • Pharmacy (66)
  • Medications (53)
  • Supplements (3)
  • Investments (1)
Tag Clouds
  • online pharmacy
  • generic drugs
  • medication safety
  • drug interactions
  • Hatch-Waxman Act
  • medication adherence
  • online pharmacy safety
  • generic medications
  • medication side effects
  • 180-day exclusivity
  • therapeutic equivalence
  • bioequivalence
  • fertility
  • erectile dysfunction
  • medication
  • inflammation
  • hair loss treatment
  • affordable medications
  • online pharmacy alternatives
  • prescription savings
  • About RXFast.net
  • Terms & Conditions
  • Privacy Policy
  • GDPR Compliance Framework
  • Contact Us

©2026 rxfast.net. All rights reserved